UBS Group’s UroGen Pharma URGN Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $4.23M | Sell |
|
|||||
|
2025
Q1 | $13M | Buy |
|
|||||
|
2024
Q4 | $9.83M | Buy |
|
|||||
|
2024
Q3 | $581K | Buy |
|
|||||
|
2024
Q2 | $199K | Sell |
|
|||||
|
2024
Q1 | $643K | Buy |
|
|||||
|
2023
Q4 | $376K | Buy |
|
|||||
|
2023
Q3 | $269K | Buy |
|
|||||
|
2023
Q2 | $146K | Buy |
|
|||||
|
2023
Q1 | – | Sell |
|
|||||
|
2022
Q4 | $201K | Sell |
|
|||||
|
2022
Q3 | $363K | Buy |
|
|||||
|
2022
Q2 | $212K | Sell |
|
|||||
|
2022
Q1 | $473K | Buy |
|
|||||
|
2021
Q4 | $453K | Buy |
|
|||||
|
2021
Q3 | $22K | Buy |
|
|||||
|
2021
Q2 | $14K | Sell |
|
|||||
|
2021
Q1 | $147K | Sell |
|
|||||
|
2020
Q4 | $215K | Buy |
|
|||||
|
2020
Q3 | $49K | Sell |
|
|||||
|
2020
Q2 | $237K | Sell |
|
|||||
|
2020
Q1 | $204K | Sell |
|
|||||
|
2019
Q4 | $730K | Buy |
|
|||||
|
2019
Q3 | $334K | Buy |
|
|||||
|
2019
Q2 | $124K | Buy |
|
|||||
|
2019
Q1 | $102K | Sell |
|
|||||
|
2018
Q4 | $186K | Buy |
|
|||||
|
2018
Q3 | $154K | Sell |
|
|||||
|
2018
Q2 | $272K | Buy |
|
|||||
|
2018
Q1 | $180K | Buy |
|
|||||
|
2017
Q4 | $102K | Buy |
|
|||||
|
2017
Q3 | $32K | Buy |
|
|||||
|
2017
Q2 | $7K | Buy |
|